Skip to content

Supplier News

PepsiCo introduces aspartame-free Diet Pepsi

PepsiCo introduces aspartame-free Diet Pepsi

PepsiCo has unveiled aspartame-free Diet Pepsi as a new option for cola fans. “Diet cola drinkers in the U.S. told us they wanted aspartame-free Diet Pepsi, and we’re delivering,” said Seth Kaufman, senior vice president Pepsi and Flavors portfolio, PepsiCo North America Beverages.

Galderma launches two Benzac acne products

Galderma launches two Benzac acne products

Benzac Skin Refining Mask and Benzac Acne Eliminating Cleanser. “The addition of Benzac Skin Refining Mask and Benzac Acne Eliminating Cleanser allows teens to customize a highly effective skin care regimen that quickly clears up mild-to-moderate

Upsher-Smith gains approval for Namenda generic

Upsher-Smith Laboratories Inc. has received approval from the Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, a treatment for Alzheimer’s disease, in strengths of 5 mg and 10 mg.

Daymon Worldwide names new CEO

Daymon Worldwide names new CEO

Jim Holbrook has been appointed as chief executive officer at Daymon Worldwide, succeeding Carla Cooper, who is retiring. The consumables retail marketing firm said Thursday that Holbrook is slated to take the helm as CEO on Sept. 1. He also will join Daymon’s board of directors.

AmerisourceBergen creates nonprofit foundation

AmerisourceBergen creates nonprofit foundation

AmerisourceBergen Corp. has launched the AmerisourceBergen Foundation, a nonprofit charitable organization that provides grants to health- and pharmaceutical-related causes and educational opportunities.

Aurobindo cleared to market Xanax generic

Aurobindo cleared to market Xanax generic

Aurobindo Pharma Ltd. has gained Food and Drug Administration approval for alprazolam tablets, a medication for anxiety. Aurobindo said its alprazolam product — available in dosages of 0.25 mg, 0.5 mg, 1 mg and 2 mg — is a generic version of Xanax tablets from Pfizer Inc. Part of a group of

DenTek launches e-commerce website

DenTek launches e-commerce website

DenTek has gone live with a new branded website featuring full e-commerce capabilities. The oral care brand said Monday that DenTek.com now provides oral care product information and tips plus the ability for consumers to buy items directly through the site.

Pfizer to buy U.S. rights for potential MS generic drug

Pfizer to buy U.S. rights for potential MS generic drug

Pfizer Inc. has entered into an agreement with Synthon to acquire the exclusive U.S. commercialization rights for glatiramer acetate, a potential generic version of Teva Pharmaceuticals’ Copaxone for the treatment of relapsing remitting multiple sclerosis (RRMS).

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S.